Enrichment Program

Introduction and Goals

The RCLD conducts a well-established and highly successful enrichment program through our seminar series, annual symposium and meetings of Special Interest Groups of our Themes. We closely interact with the Southern California Center for Alcoholic Liver and Pancreatic Disease, sharing a seminar time slot with each conducting complementary annual symposia in the spring and winter. The enrichment program is of great benefit to our senior and junior faculty members and the many postdoctoral fellows and graduate students who work with members as well as the entire University community. Recent changes in the enrichment program are aimed at the research progress of junior faculty, allowing for more interactions with trainees during biannual poster sessions and strengthened interactions within our SIG programs by offering twice yearly minisymposium/workshops geared to specific areas of research interests.

Goals of the enrichment program are to:

  1. Organize and support a seminar series, which provides an educational forum to expose Center members and their staff to cutting edge science relevant to the themes of the Center.
  2. Support an Annual Symposium to facilitate interactions with and feedback from the External Scientific Advisory Board and the constructive review and monitoring of P/F projects.
  3. Provide, through the seminar series, a forum for mentoring and enhancement of collaborations through research-in-progress presentations and poster sessions, which provide junior faculty and trainees with feedback and established investigators with an opportunity to discuss roadblocks in the progress of their work and provide critical review of their studies
  4. Develop a biannual SIG specific minisymposium/workshop to promote collaborations within the SIG by inviting non-USC leaders in the field.

Director

Dr. Andrew Stolz, M.D.: Dr Stolz has assumed the responsibility for the ongoing seminar series and the Annual Symposium. He is an experienced physician scientist and longstanding Center member. His research focus spans from basic to translational research in liver disease and he is well-versed in both.

Current Enrichment Activities 2015

Fall (Sept-Dec) and Spring (April-June) Weekly Seminar Series

Spring Annual Symposium

Planned for 2016

Two mini-symposia organized by thematic special interest groups (SIG)

Increased opportunities for the Center’s junior faculty and fellows to receive feedback on their research:

  • two junior faculty shear monthly seminar
  • biannual evening poster session for postdoctoral fellows

Research Seminars (2013-2014)

2013
Jorge Moscat, Sanford-Burnham Medical Research Institute, “Cancer Metabolism and the p62 network” Aldons (Jake) Lusis, UCLA, “A systems genetics approach to dissect common, complex metabolic and cardiovascular disorders”
Terrence Donohue, Univ of Nebraska Medical Center, “Influence of alcohol exposure on hepatic autophagy and proteostasis”
Mark Frey, Children’s Hospital Los Angeles/USC, “Regulation of intestinal epithelial integrity by ErbB4: not just another brick in the wall”
Ratna Ray, Saint Louis Univ, “Hepatitis C virus mediated innate regulation”
Laura James, Univ of Arkansas for Medical Sciences, “Biomarkers of acetaminophen toxicity”
Arun Sanyal, Virginia Commonwealth University, “Emerging trends in evaluation and management of NASH” – (Telfer Reynolds Lecture)
Konstantinos Lazarides, Mayo Clinic, “Dissecting the genetic and environmental underpinnings of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)”
Ronald Sokol, Children’s Hospital Colorado, “Parenteral nutrition-associated liver disease and innate immune activation: a tale of two lipids?”
2014
Natalie Torok, University of Davis Medical Center, “NADPH oxidase as treatment targets for liver fibrosis”
Peter Sarnow, Stanford University, “interactions of hepatitis C viral RNA with host microRNA miR-122 in infected cells”
Douglas Feldman, USC, “Erasure of DNA methylation in NASH/ASH diseases”
Pinchas Cohen, USC, “Mitochondrial-derived peptides”
Wen-Xing Ding, The University of Kansas Medical Center, “Mechanisms of autophagy in protecting against drug-induced liver injury”
Anja Jaeschke, Metabolic Diseases Institute, “Role of mixed-lineage kinase 3 in cellular stress response”
Nilabh Shastri, UC Berkeley, “All peptides that fit: producing the peptide-MHC repertoire for immunity”
Vijay Shah, Mayo Clinic, “Fibrosis and portal hypertension: tales from the sinusoids”
Deborah Rubin, Washington University School of Medicine, St. Louis, “Intestinal stem cell and metabolic responses during gut adaptation in short bowel syndrome”
James Ou, USC, “Hepatitis B virus replication and persistence in mice: Effects of autophagy, gender and mother”
Kim Newton, UC San Diego, “Necroptosis signaling and inflammation”
Jay H. Hoofnagle, NIH, “Drug induced liver injury: Clinical phenotypes” – (Telfer Reynolds Memorial Lecture)

Most Recent Annual Symposium

19th-ANNUAL-SYMPOSIUM-PROGRAM-OF-EVENTS

Upcoming Annual Symposium

RCLD_Symposium_Flyer_2016
Click here for flyer.